News | February 18, 2022
AptarGroup reported 2021 sales at US $3.23 billion
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
APF Futurity is made from polyolefin materials with no metal parts or recycling disruptors
Subscribe To Our Newsletter & Stay Updated
